Flagship Biosciences

Founded in 2009 and headquartered in Boulder, Colorado, Flagship Biosciences operates as a high-value contract research organization (CRO) focused on tissue-based diagnostics and data analysis. The company's core differentiator is its integration of board-certified pathological expertise with proprietary AI/ML-powered image analysis tools to extract quantitative insights from immunohistochemistry (IHC) and digital spatial profiling data. It primarily serves pharmaceutical and biotech companies engaged in oncology and other therapeutic areas, providing critical biomarker and pathology support from research through clinical trials to improve patient outcomes.

Proprietary AI/ML-powered tissue image analysis and genomics data interpretation platform, integrating digital pathology, quantitative biomarker analysis, and spatial biology capabilities within a CAP-CLIA certified environment.

Flagship competes in a fragmented market against large, full-service CROs with growing digital capabilities, specialized digital pathology labs, and pure-play AI software vendors. Its differentiator is the tight integration of board-certified pathological expertise with a flexible, client-friendly AI platform and a clinical-grade operational infrastructure.